BTS Guidelines for the Management of Community Acquired Pneumonia in Adults

Overview

Journal Thorax

Date 2001 Nov 20

PMID 11713364

Citations 150

Affiliations

Soon will be listed here.

Citing Articles

Modified R-GLIM Score Is a Good Prognostic Tool to Predict a Long-Term Prognosis in Poor Conditioned Elderly Patients with Aspiration Pneumonia, a Pilot Study.

Wakita Y, Asai N, Ohashi W, Mori N, Maekawa M, Mikamo H Geriatrics (Basel). 2024; 9(5).

PMID: 39311243 PMC: 11417869. DOI: 10.3390/geriatrics9050118.

[Guidelines for the management of community pneumonia in adult who needs hospitalization].

Alvarez-Rocha L, Alos J, Blanquer J, Alvarez-Lerma F, Garau J, Guerrero A Med Intensiva. 2024; 29(1):21-62.

PMID: 38620135 PMC: 7131443. DOI: 10.1016/S0210-5691(05)74199-1.

Awareness and Knowledge of Pneumococcal Vaccination in Cardiology Outpatient Clinics and the Impact of Physicians' Recommendations on Vaccination Rates.

Ekin T, Kis M, Gungoren F, Akhan O, Atici A, Kunak A Vaccines (Basel). 2023; 11(4).

PMID: 37112684 PMC: 10142867. DOI: 10.3390/vaccines11040772.

Tomography and Prognostic Indices in the State of the Art of Evaluation in Hospitalized Patients with COVID-19 Pneumonia.

Criales-Vera S, Saucedo-Orozco H, Iturralde-Torres P, Martinez-Mota G, Davila-Medina E, Guarner-Lans V Pathogens. 2022; 11(11).

PMID: 36365031 PMC: 9697491. DOI: 10.3390/pathogens11111281.

Q Fever as a Cause of Community-Acquired Pneumonia in French Guiana.

Epelboin L, Mahamat A, Bonifay T, Demar M, Abboud P, Walter G Am J Trop Med Hyg. 2022; 107(2):407-415.

PMID: 35977720 PMC: 9393466. DOI: 10.4269/ajtmh.21-0711.

References

Bartlett J, Dowell S, Mandell L, File Jr T, Musher D, Fine M . Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000; 31(2):347-82. PMC: 7109923. DOI: 10.1086/313954. View

Mandell L, Marrie T, Grossman R, Chow A, Hyland R . Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis. 2000; 31(2):383-421. DOI: 10.1086/313959. View

Simpson J, Macfarlane J, Watson J, Woodhead M . A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales. British Thoracic Society Research Committee and Public Health Laboratory Service. Thorax. 2000; 55(12):1040-5. PMC: 1745667. DOI: 10.1136/thorax.55.12.1040. View

Woodhead M, MacFarlane J . Local antibiotic guidelines for adult community-acquired pneumonia (CAP): a survey of UK hospital practice in 1999. J Antimicrob Chemother. 2000; 46(1):141-3. DOI: 10.1093/jac/46.1.141. View

Nathwani D, Rubinstein E, Barlow G, Davey P . Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?. Clin Infect Dis. 2001; 32(5):728-41. DOI: 10.1086/319216. View

Lim W, Macfarlane J, Boswell T, Harrison T, Rose D, Leinonen M . Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax. 2001; 56(4):296-301. PMC: 1746017. DOI: 10.1136/thorax.56.4.296. View

Siegel R, Alicea M, Lee A, Blaiklock R . Comparison of 7 versus 10 days of antibiotic therapy for hospitalized patients with uncomplicated community-acquired pneumonia: a prospective, randomized, double-blind study. Am J Ther. 2001; 6(4):217-22. DOI: 10.1097/00045391-199907000-00007. View

Beall D, Scott Jr W, Kuhlman J, Hofmann L, Moore R, Mundy L . Utilization of computed tomography in patients hospitalized with community-acquired pneumonia. Md Med J. 1998; 47(4):182-7. View

Syrjala H, Broas M, Suramo I, Ojala A, Lahde S . High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis. 1998; 27(2):358-63. DOI: 10.1086/514675. View

10.

Edelstein P . Antimicrobial chemotherapy for Legionnaires disease: time for a change. Ann Intern Med. 1998; 129(4):328-30. DOI: 10.7326/0003-4819-129-4-199808150-00012. View

11.

Norrby S, Petermann W, Willcox P, Vetter N, SALEWSKI E . A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Scand J Infect Dis. 1998; 30(4):397-404. DOI: 10.1080/00365549850160710. View

12.

Settle C, Wilcox M, Fawley W, Corrado O, Hawkey P . Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam. Aliment Pharmacol Ther. 1999; 12(12):1217-23. DOI: 10.1046/j.1365-2036.1998.00428.x. View

13.

Beyer W, de Bruijn I, Palache A, Westendorp R, Osterhaus A . Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. Arch Intern Med. 1999; 159(2):182-8. DOI: 10.1001/archinte.159.2.182. View

14.

Pallares R, Viladrich P, Linares J, Cabellos C, Gudiol F . Impact of antibiotic resistance on chemotherapy for pneumococcal infections. Microb Drug Resist. 1999; 4(4):339-47. DOI: 10.1089/mdr.1998.4.339. View

15.

Agastya G, Ailani R, Mukunda B, Shekar R . Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia. Arch Intern Med. 1999; 159(3):266-70. DOI: 10.1001/archinte.159.3.266. View

16.

Nichol K, Baken L, Nelson A . Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999; 130(5):397-403. DOI: 10.7326/0003-4819-130-5-199903020-00003. View

17.

ODOHERTY B, Muller O . Randomized, multicentre study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of adults with mild to moderate community-acquired pneumonia. Azithromycin Study Group. Eur J Clin Microbiol Infect Dis. 1999; 17(12):828-33. DOI: 10.1007/s100960050201. View

18.

Wilde J, McMillan J, Serwint J, Butta J, ORiordan M, Steinhoff M . Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA. 1999; 281(10):908-13. DOI: 10.1001/jama.281.10.908. View

19.

Ramirez J, Unowsky J, Talbot G, Zhang H, Townsend L . Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia. Clin Ther. 1999; 21(1):103-17. DOI: 10.1016/S0149-2918(00)88271-5. View

20.

Leroy O, Guilley J, Georges H, Choisy P, Guery B, Alfandari S . Effect of hospital-acquired ventilator-associated pneumonia on mortality of severe community-acquired pneumonia. J Crit Care. 1999; 14(1):12-9. DOI: 10.1016/s0883-9441(99)90003-5. View